Susquehanna International Group, LLP Summit Therapeutics Inc. Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 77,224 shares of SMMT stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,224

Previous 366,395 78.92%

Holding current value

$1.57 Million

Previous $8.02 Million 82.83%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$17.52 - $23.46 $5.07 Million - $6.78 Million	-289,171 Reduced 78.92%	77,224 $1.38 Million
Q3 2024 Nov 14, 2024	BUY	$6.89 - $31.93 $775,772 - $3.6 Million	112,594 Added 44.36%	366,395 $8.02 Million
Q2 2024 Aug 15, 2024	BUY	$2.39 - $10.92 $220,986 - $1.01 Million	92,463 Added 57.31%	253,801 $1.98 Million
Q1 2024 May 07, 2024	SELL	$2.55 - $5.07 $175,980 - $349,890	-69,012 Reduced 29.96%	161,338 $667,000
Q4 2023 Feb 14, 2024	BUY	$1.67 - $2.83 $173,644 - $294,260	103,979 Added 82.28%	230,350 $601,000
Q3 2023 Nov 14, 2023	SELL	$1.54 - $2.42 $389,575 - $612,189	-252,971 Reduced 66.69%	126,371 $236,000
Q2 2023 Aug 11, 2023	SELL	$1.32 - $2.81 $1.73 Million - $3.68 Million	-1,309,223 Reduced 77.53%	379,342 $952,000
Q1 2023 May 16, 2023	BUY	$1.38 - $5.41 $1.94 Million - $7.62 Million	1,408,141 Added 502.15%	1,688,565 $2.95 Million
Q4 2022 Feb 14, 2023	BUY	$0.68 - $5.31 $135,127 - $1.06 Million	198,717 Added 243.21%	280,424 $1.19 Million
Q3 2022 Nov 14, 2022	BUY	$0.89 - $1.63 $51,682 - $94,654	58,070 Added 245.67%	81,707 $97,000
Q2 2022 Aug 15, 2022	BUY	$0.92 - $2.38 $21,746 - $56,256	23,637 New	23,637 $24,000
Q1 2022 May 16, 2022	SELL	$2.0 - $3.45 $28,922 - $49,890	-14,461 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.45 - $5.64 $4,020 - $9,255	1,641 Added 12.8%	14,461 $39,000
Q3 2021 Nov 15, 2021	SELL	$4.83 - $8.27 $584,372 - $1 Million	-120,988 Reduced 90.42%	12,820 $64,000
Q1 2021 May 17, 2021	BUY	$5.17 - $11.19 $547,616 - $1.19 Million	105,922 Added 379.84%	133,808 $785,000
Q4 2020 Feb 16, 2021	BUY	$3.25 - $6.0 $90,629 - $167,316	27,886 New	27,886 $131,000

Others Institutions Holding SMMT

# of Institutions

232

Shares Held

83.1M

Call Options Held

1.66M

Put Options Held

2.56M

View Full List

About Summit Therapeutics Inc.

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $4.09B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

More about SMMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Summit Therapeutics Inc. Transaction History